# Carcinoma, Non-Small-Cell Lung trials recruiting: 182 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 182 trials with no drug phase for Carcinoma, Non-Small-Cell Lung that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Carcinoma, Non-Small-Cell Lung trials with no drug phase: 182 rows for $9.10, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 8 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/carcinoma-non-small-cell-lung

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 182
- Recruiting or not yet: 182
- Read on: November 19, 2026

## Trials

The 25 newest of 182, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 6, 2026 | NCT07922135 | Moderately Hypofractionated Versus Conventional Chemoradiotherapy With Consolidation Immunotherapy in Patients With Unresectable... | Trans Tasman Radiation Oncology Group | Not applicable | Not yet recruiting | Stage III NSCLC | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922135) |
| October 27, 2026 | NCT07898241 | Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors | Northwestern University | Not applicable | Not yet recruiting | Lung Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Lung | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898241) |
| October 22, 2026 | NCT07889297 | Pulsed Field Ablation for the Treatment of Malignant Lung Tumors | Shanghai Chest Hospital | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer, Pulmonary Metastases | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889297) |
| October 21, 2026 | NCT07886359 | Effects of Supervised Aerobic Exercise on Biomarkers in Patients With nSCLC Receiving Immunotherapy | Izmir Bakircay University | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer, Aerobic Exercise, Immunotherapy, Biomarker, Tumor Microenvironment, Handgrip Strength... | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886359) |
| October 19, 2026 | NCT07879768 | Acupuncture and Laser Acupuncture for Advanced Non-Small Cell Lung Cancer | China Medical University, Taiwan | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07879768) |
| October 14, 2026 | NCT07873086 | MRD-Guided Aumolertinib-Based Adjuvant Therapy for Resected EGFR-Mutant NSCLC | Peking University People's Hospital | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07873086) |
| October 9, 2026 | NCT07869329 | Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients | Duke University | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer, Radiation-Induced Cardiac Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869329) |
| October 9, 2026 | NCT07869186 | Dermatological Effects and Quality of Life in Oncology Patients | European Institute of Oncology | Not applicable | Not yet recruiting | Breast Cancer, Ovarian Cancer, NSCLC (Non-small Cell Lung Cancer), Melanoma (Skin Cancer), Gynecological Cancer | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07869186) |
| September 30, 2026 | NCT07849712 | An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or... | Zhejiang Cancer Hospital | Not applicable | Not yet recruiting | Non-small Cell Lung Cancer (NSCLC) Stage IV, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-small Cell... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849712) |
| September 22, 2026 | NCT07833085 | CAIX-targeted PET/CT in Solid Tumors | Zhongnan Hospital | Not applicable | Recruiting | Malignant Solid Tumors, Clear Cell Renal Cell Carcinoma, Lung Cancer (NSCLC), Breast Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07833085) |
| September 18, 2026 | NCT07828938 | Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality... | Fondation Hôpital Saint-Joseph | Not applicable | Not yet recruiting | Lung Cancer (Non-Small Cell) | 2,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07828938) |
| September 16, 2026 | NCT07823855 | SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC | Second Affiliated Hospital, Zhejiang University, School of Medicine | Not applicable | Recruiting | Non-Small Cell Lung Cancer | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07823855) |
| September 16, 2026 | NCT07823725 | TailorDose Lung: Decentralized TDM of Taxanes and ALK Inhibitors Using Capillary Self-Sampling | Karolinska Institutet | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer (MeSH Term: Carcinoma, Non-Small-Cell Lung) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07823725) |
| September 14, 2026 | NCT07818135 | Comparison of Biportal Versus Multiportal Robotic Approaches for Pulmonary Resection in NSCLC | Sponsor not shown (see the record) | Not applicable | Recruiting | Non-Small Cell Lung Cancer | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818135) |
| September 11, 2026 | NCT07815873 | Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers | European Institute of Oncology | Not applicable | Not yet recruiting | Non Small Cell Lung Cancer, Melanoma (Skin Cancer), Endometrial Cancer, Cervical Cancer | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07815873) |
| September 9, 2026 | NCT07809763 | Wireless Wearable Home Prehabilitation for Older Adults With NSCLC | West China Hospital | Not applicable | Recruiting | Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery, Prehabilitation | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07809763) |
| September 3, 2026 | NCT07801430 | Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLC | Fudan University | Not applicable | Recruiting | Non-Small Cell Lung Cancer | 384 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07801430) |
| September 2, 2026 | NCT07799194 | Percutaneous Pulsed Electric Field Ablation for Early-Stage NSCLC and Lung Oligometastases: A Safety and Efficacy Study | Energenx Medical LTD. | Not applicable | Not yet recruiting | Lung Cancer (NSCLC) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799194) |
| September 1, 2026 | NCT07797075 | Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection | West China Hospital | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery | 222 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07797075) |
| August 27, 2026 | NCT07789912 | BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies | University of Miami | Not applicable | Recruiting | Leptomeningeal Metastasis, Breast Cancer, Lung Cancer (NSCLC) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07789912) |
| August 26, 2026 | NCT07786909 | ERICA-02 Study : Impact of Physical Exercise on the Tumor Immune Microenvironment in Patients Treated With Neoadjuvant Chemoimmunotherapy... | Centre Leon Berard | Not applicable | Recruiting | Lung Neoplasms, Non Small Cell Lung Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07786909) |
| August 21, 2026 | NCT07780591 | Septum-guided Segmentectomy for 2-3 cm Clinical Stage IA3 Peripheral Non-Small Cell Lung Cancer | Shanghai Chest Hospital | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780591) |
| August 7, 2026 | NCT07751783 | Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations | Kaohsiung Medical University Chung-Ho Memorial Hospital | Not applicable | Recruiting | Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Lung Cancer... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751783) |
| August 7, 2026 | NCT07751536 | ctDNA-driven Adaptive Proton Craniospinal Irradiation in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis After Resistance to... | Sponsor not shown (see the record) | Not applicable | Recruiting | Leptomeningeal Metastasis From Lung Cancer | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751536) |
| July 29, 2026 | NCT07733492 | Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery | West China Hospital | Not applicable | Not yet recruiting | Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery | 126 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07733492) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Shanghai Chest Hospital | 6 |
| West China Hospital | 6 |
| Fudan University | 5 |
| National Taiwan University Hospital | 3 |
| Tang-Du Hospital | 3 |
| M.D. Anderson Cancer Center | 3 |
| European Institute of Oncology | 3 |
| Hacettepe University | 3 |
| Guangzhou University of Traditional Chinese Medicine | 3 |
| Northwestern University | 3 |
| Groupe Francais De Pneumo-Cancerologie | 2 |
| VA Office of Research and Development | 2 |
| Peking Union Medical College Hospital | 2 |
| Peking University People's Hospital | 2 |
| The First Affiliated Hospital of Guangzhou Medical University | 2 |
| Zhongnan Hospital | 2 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 2 |
| Ohio State University Comprehensive Cancer Center | 2 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2 |
| All India Institute of Medical Sciences | 1 |
| British Columbia Cancer Agency | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| University Medical Center Groningen | 1 |
| University of Melbourne | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 55 |
| United States | 35 |
| France | 13 |
| Italy | 8 |
| Canada | 6 |
| Denmark | 6 |
| Spain | 6 |
| Turkey (Türkiye) | 5 |
| Switzerland | 4 |
| Taiwan | 4 |
| Austria | 4 |
| Netherlands | 3 |
| Germany | 3 |
| Belgium | 3 |
| Australia | 2 |
| Israel | 2 |
| Sweden | 2 |
| India | 1 |
| Mexico | 1 |
| Indonesia | 1 |
| Hong Kong | 1 |
| Colombia | 1 |
| Ireland | 1 |
| Thailand | 1 |
| United Kingdom | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Brewing supply stores in the United States](https://specstream.ai/data/businesses/brewing-supply-stores/united-states)
- [Printing companies in the United States](https://specstream.ai/data/businesses/printing-companies/united-states)
- [Empanada restaurants in the United States](https://specstream.ai/data/businesses/empanada-restaurants/united-states)
- [Trailer rental companies in the United States](https://specstream.ai/data/businesses/trailer-rental-companies/united-states)
- [Insulation contractors in the United States](https://specstream.ai/data/businesses/insulation-contractors/united-states)
- [B2B radio and television commercials companies in the United States](https://specstream.ai/data/businesses/b2b-radio-and-television-commercials-companies/united-states)
